US979993A - Projectile. - Google Patents

Projectile. Download PDF

Info

Publication number
US979993A
US979993A US55135310A US1910551353A US979993A US 979993 A US979993 A US 979993A US 55135310 A US55135310 A US 55135310A US 1910551353 A US1910551353 A US 1910551353A US 979993 A US979993 A US 979993A
Authority
US
United States
Prior art keywords
projectile
narcotic
butt
point
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US55135310A
Inventor
Joseph Francis O'byrne
Thomas A Flood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US55135310A priority Critical patent/US979993A/en
Application granted granted Critical
Publication of US979993A publication Critical patent/US979993A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42AMMUNITION; BLASTING
    • F42BEXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B12/00Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material
    • F42B12/02Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect
    • F42B12/36Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information
    • F42B12/46Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances
    • F42B12/54Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances by implantation, e.g. hypodermic projectiles

Definitions

  • Joanna FRANCIS OBYRNE and THOMAS both citizens of the United States, and residing, respectively, at Contact, in the county of Elko and State of Fevada', and Salt Lake City,
  • FIG. 1 is a longitudinal section of a rojectile in the form of a cartridge embodying our invention and Fig. 2 is a cross sectional view on about the line 2--2 of Fig. 1. j
  • This invention is -in the nature of a projectile in the form of a bullet or missile as the case may be, especially designed for use in catching wild animals and .has for an object to provide a projectile carrying a narcotic whoseanesthetic efi'ect will so affect the animal as to render the capture and control of the same easy.
  • I provide a projectile with an opening or recess to receive an opiate, or other narcotic or anesthetizing substance and the said recessis shown as opening laterally and it is illustrated in Fig. 2 as annula" in form 'so' an annular body of the substance maybe used and I also illustrate a soluble cover or envelop which may. be of gelatin as more fully described hereinafter.
  • the projectile is in the form of a bullet B connected with a cartridge D which maybe of the ordinary construction and the bullet B has a point-B, a butt B and an axial shank B connecting the point and butt, the projectile being recessed between the point and butt forming as shown in Fig. 2 an annular recess in which the substance may be'placed and the ends of said recess 0- are undercut at C to aid in retaining the substance when applied as presently described.
  • the substance or chargeA toact as a narcotic may be apornorphine hydrochlorate, or morphine and scopolamin, or the equivalent ofscopolamin, hyoscin', or morphine sulfate, or the hydrochlorate or in fact any of the alkaloids or other substances which will tend to produce sleep or stupor when taken up by thetissues.
  • the body of the projectile may be of lead, steel or the -like or other heavy metal while with smaller thin skinned animals some soluble material or such substances as magnesium may be employed as the metalrnag nesium will ordinarily be absorbed byfithe animal tissues in from two to, tour Weeks after entering the same and will leave no trace. This is desirable as it avoids extract the bullet as a. steel bullet 'or steel jacketed bullet will have to be used owing tothe-fact that magnesium will not penetrate due to its low specificgravity.
  • the cover E s of some soluble substance: preferably gelatin and is in the formofa cylindrical casing fitting between the point and butt of the projectile and coinciding in its external circumference with that oi said point and butt and forms an inclosure: or
  • the animal In operation the animal is .shot in some" fleshy part with a powder charge or other force sufficient to just penetrate the skin or for a short distance into the tissues and melt or dissolve in from ten to fifteen minutes, more or less, and the blood will absorb the substance A and the animal will in from twenty to forty minutes come into the influence of the substance when-it can be easily as Y when in the tissues the gelatin cover will.
  • the drug material A maybe used in the dry form, or if desired in the shape in which it comes for hypodermic injections and when constructed as shown in Figs. 1 and .2 the drug charge is cylindrical or tubular in shape.
  • the gelatin is employed for strength and to avoid climatic changes in the drug. If
  • the gelatin can be is hit by the projectile.
  • the cartridge shell extends-at D over the latera opening in the projectile and over the charge and the gelatin cover therefor, when such gelatin cover is employed. .By-extending the cartridge shell over the narcotic charge the dru is protected from the weather by the shell and is also so incased as to prevent mechanical injury or displacement thereof.
  • gelatin cover may or may not be employed, as while it increases the safety and certainty of op eration, it is not really necessary when the drug is protected by the extension ofthe cartridge shell as shown and above described.
  • some suitable binder may be incorporated with or used otherwise with the drug as ordinarily the drug would not be strong enough to stand the shock of leaving the rifle unless held in some way to the projectile.
  • a projectile having a recess or opening, a narcotic therein and a gelatin like cover for said recess or opening.
  • a projectile having a point, a butt, a connection between the point and the butt and a narcotic between the point and butt and alongside the connection and a gelatinlike cylinder inclosing the narcotic.
  • a projectile having a point or butt and a connection between the same of reduced diameter whereby an annular recess is pro- Vided surroundin the connection, the ends of the said recess eingundercut and a narcotic held in said recess.
  • a projectile of magnesium having a recess or opening and a narcotic therein substantially as described.
  • a projectile of magnesium having a point, a butt spaced therefrom and a relatively smaller connecting portion between the point and butt and a narcotic carried between the point and butt.
  • a projectile of magnesium having a point or'butt, a relatively smaller connecting portion between the same and concentric therewith, a narcotic surrounding said connecting portion between the point and butt and a gelatin cover for the narcotic.
  • a projectile of'magnesium having a laterally openin recess, a narcotic therein and a soluble c osure extending over the said recess.
  • rojectile having an annular recess, a narcotic therein and a gelatin like cylinder

Description

J. F. OBYRNE & T. A. FLOOD.
'PROJEGTILE.
APPLICATION FILED MAR. 24, 1910.
979,993. Patented Dec. 27, 1910.
WITNESSES INIVENIORJ J06EPH f0. firfi/ve OMHS 1.00 a W v W lu A TTORNE Y8 err srrns remains true JOSEPH FRANCIS OBYRNE, OF CONTACT, NEVADA, AND THOMAS A. FLOOD, 0T SALT LAKE CITY, UTAH.
Specification of Letters latent Patented Dec. 27,1919.
Application filed March 24, 1910. Serial *No; 551,353.
To all whom it may concern.
Be it. known that we, Joanna FRANCIS OBYRNE and THOMAS; A. Fnoon, both citizens of the United States, and residing, respectively, at Contact, in the county of Elko and State of Fevada', and Salt Lake City,
jectiles and consists "in certain novel constru'ctions and combinations of parts as will be hereinafter described and claimed.
In the drawing Figure 1 is a longitudinal section of a rojectile in the form of a cartridge embodying our invention and Fig. 2 is a cross sectional view on about the line 2--2 of Fig. 1. j
This invention is -in the nature of a projectile in the form of a bullet or missile as the case may be, especially designed for use in catching wild animals and .has for an object to provide a projectile carrying a narcotic whoseanesthetic efi'ect will so affect the animal as to render the capture and control of the same easy.
In the construction shown, I provide a projectile with an opening or recess to receive an opiate, or other narcotic or anesthetizing substance and the said recessis shown as opening laterally and it is illustrated in Fig. 2 as annula" in form 'so' an annular body of the substance maybe used and I also illustrate a soluble cover or envelop which may. be of gelatin as more fully described hereinafter.
In the construction shown the projectile is in the form of a bullet B connected with a cartridge D which maybe of the ordinary construction and the bullet B has a point-B, a butt B and an axial shank B connecting the point and butt, the projectile being recessed between the point and butt forming as shown in Fig. 2 an annular recess in which the substance may be'placed and the ends of said recess 0- are undercut at C to aid in retaining the substance when applied as presently described. The substance or chargeA toact as a narcotic may be apornorphine hydrochlorate, or morphine and scopolamin, or the equivalent ofscopolamin, hyoscin', or morphine sulfate, or the hydrochlorate or in fact any of the alkaloids or other substances which will tend to produce sleep or stupor when taken up by thetissues. V
In the case of the larger animals like the elephant and rhinoceros with thick skins, the body of the projectile may be of lead, steel or the -like or other heavy metal while with smaller thin skinned animals some soluble material or such substances as magnesium may be employed as the metalrnag nesium will ordinarily be absorbed byfithe animal tissues in from two to, tour Weeks after entering the same and will leave no trace. This is desirable as it avoids extract the bullet as a. steel bullet 'or steel jacketed bullet will have to be used owing tothe-fact that magnesium will not penetrate due to its low specificgravity. "The cover E s of some soluble substance: preferably gelatin and is in the formofa cylindrical casing fitting between the point and butt of the projectile and coinciding in its external circumference with that oi said point and butt and forms an inclosure: or
envelop retaining the substance A until it has entered the animal.
In operation the animal is .shot in some" fleshy part with a powder charge or other force sufficient to just penetrate the skin or for a short distance into the tissues and melt or dissolve in from ten to fifteen minutes, more or less, and the blood will absorb the substance A and the animal will in from twenty to forty minutes come into the influence of the substance when-it can be easily as Y when in the tissues the gelatin cover will.
captured-and tied up. The drug material A maybe used in the dry form, or if desired in the shape in which it comes for hypodermic injections and when constructed as shown in Figs. 1 and .2 the drug charge is cylindrical or tubular in shape.
The gelatin is employed for strength and to avoid climatic changes in the drug. If
quick action is desired, the gelatin can be is hit by the projectile.
106 knocked off orotherwise removed when the drug will begin to act as soon as the animal calculated for the animals or birds on which" it is designed to use the rojectile and for birds the projectile may e made founder ,and shorter for small rifles.
It is found practice that in to secure a quickaction of the drug charge.
It will be noticed that the cartridge shellextends-at D over the latera opening in the projectile and over the charge and the gelatin cover therefor, when such gelatin cover is employed. .By-extending the cartridge shell over the narcotic charge the dru is protected from the weather by the shell and is also so incased as to prevent mechanical injury or displacement thereof.
a It will be understood that the gelatin cover may or may not be employed, as while it increases the safety and certainty of op eration, it is not really necessary when the drug is protected by the extension ofthe cartridge shell as shown and above described. When the gelatin cover is omitted some suitable binder may be incorporated with or used otherwise with the drug as ordinarily the drug would not be strong enough to stand the shock of leaving the rifle unless held in some way to the projectile.
We claim 1. A projectile having a recess or opening, a narcotic therein and a gelatin like cover for said recess or opening.
2. A projectile having a point, a butt, a connection between the point and the butt and a narcotic between the point and butt and alongside the connection and a gelatinlike cylinder inclosing the narcotic.
3. A. projectile of material adapted to be absorbed by animal tissue and having a point and butt and a central connection bee izvti'een the same and a narcotic between the point and butt and encircling the connection.v i
inclosing the narcotic.
j 3 5. A projectile having a point or butt and a connection between the same of reduced diameter whereby an annular recess is pro- Vided surroundin the connection, the ends of the said recess eingundercut and a narcotic held in said recess. v
6. A projectile of magnesium having a recess or opening and a narcotic therein substantially as described.
7. A projectile of magnesium having a point, a butt spaced therefrom and a relatively smaller connecting portion between the point and butt and a narcotic carried between the point and butt.
8. A projectile of magnesium having a point or'butt, a relatively smaller connecting portion between the same and concentric therewith, a narcotic surrounding said connecting portion between the point and butt and a gelatin cover for the narcotic.
9. A projectile of'magnesium having a laterally openin recess, a narcotic therein and a soluble c osure extending over the said recess.
JOSEPH FRANCISJOBYRNE. THOMAS A. FLOOD.
Witnesses to the signature of Joseph F.
OByrne:
WILLIAM GRANT McCoY, ARTHUR GRAHAM WILLIAMS.
Witnesses to the signature of Thomas A. Flood; I
H. N. MAYO, J. 0. Snow.
rojectile having an annular recess, a narcotic therein and a gelatin like cylinder
US55135310A 1910-03-24 1910-03-24 Projectile. Expired - Lifetime US979993A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US55135310A US979993A (en) 1910-03-24 1910-03-24 Projectile.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55135310A US979993A (en) 1910-03-24 1910-03-24 Projectile.

Publications (1)

Publication Number Publication Date
US979993A true US979993A (en) 1910-12-27

Family

ID=3048367

Family Applications (1)

Application Number Title Priority Date Filing Date
US55135310A Expired - Lifetime US979993A (en) 1910-03-24 1910-03-24 Projectile.

Country Status (1)

Country Link
US (1) US979993A (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326129A (en) * 1965-09-01 1967-06-20 Bert B Gould Miniature disappearing projectile
US3837284A (en) * 1973-02-22 1974-09-24 R Waldeisen Dry charge hypodermic projectile
USB524121I5 (en) * 1974-11-15 1976-02-03
US3948263A (en) * 1974-08-14 1976-04-06 Minnesota Mining And Manufacturing Company Ballistic animal implant
NL7601017A (en) * 1976-02-02 1977-08-04 Minnesota Mining & Mfg Ballistically implantable projectile for animals - for controlled sustained release of biologically active materials on contact with animal body fluids
NL7601020A (en) * 1976-02-02 1977-08-04 Minnesota Mining & Mfg Ballistic animal inoculation projectile - with an antigen within a polymer body permitting antigen release
US6331310B1 (en) 1994-12-02 2001-12-18 Quadrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6584910B1 (en) 2002-04-19 2003-07-01 David J. Plass Animal syringe system
US20030140813A1 (en) * 2002-01-29 2003-07-31 Felix Rosenkranz Barricade-penetrator
US20030159612A1 (en) * 2002-02-28 2003-08-28 Terrance Ziemack Ballistic implant system and methods
US7300919B2 (en) 1992-09-29 2007-11-27 Nektar Therapeutics Pulmonary delivery of active fragments of parathyroid hormone
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US7521069B2 (en) 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326129A (en) * 1965-09-01 1967-06-20 Bert B Gould Miniature disappearing projectile
US3837284A (en) * 1973-02-22 1974-09-24 R Waldeisen Dry charge hypodermic projectile
US3948263A (en) * 1974-08-14 1976-04-06 Minnesota Mining And Manufacturing Company Ballistic animal implant
DE2603894A1 (en) * 1974-08-14 1977-08-04 Minnesota Mining & Mfg BALLISTIC IMPLANTABLE MOLDED BODY FOR THE CONTROLLED DELIVERY OF ACTIVE SUBSTANCES
USB524121I5 (en) * 1974-11-15 1976-02-03
US3982536A (en) * 1974-11-15 1976-09-28 Minnesota Mining And Manufacturing Company Ballistic inoculation of animals and projectile therefor
NL7601017A (en) * 1976-02-02 1977-08-04 Minnesota Mining & Mfg Ballistically implantable projectile for animals - for controlled sustained release of biologically active materials on contact with animal body fluids
NL7601020A (en) * 1976-02-02 1977-08-04 Minnesota Mining & Mfg Ballistic animal inoculation projectile - with an antigen within a polymer body permitting antigen release
US7300919B2 (en) 1992-09-29 2007-11-27 Nektar Therapeutics Pulmonary delivery of active fragments of parathyroid hormone
US7521069B2 (en) 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6565871B2 (en) 1994-12-02 2003-05-20 Elan Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6331310B1 (en) 1994-12-02 2001-12-18 Quadrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US7785631B2 (en) 1994-12-02 2010-08-31 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US20040052825A1 (en) * 1994-12-02 2004-03-18 Roser Bruce J. Solid dose delivery vehicle and methods of making same
US6811792B2 (en) 1994-12-02 2004-11-02 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6893657B2 (en) 1994-12-02 2005-05-17 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US7056495B2 (en) 1994-12-02 2006-06-06 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US7780991B2 (en) 1994-12-02 2010-08-24 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7744925B2 (en) 1994-12-02 2010-06-29 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US8168223B1 (en) 1997-09-29 2012-05-01 Novartis Pharma Ag Engineered particles and methods of use
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8349294B2 (en) 2000-05-10 2013-01-08 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US9439862B2 (en) 2000-05-10 2016-09-13 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside
US20030140813A1 (en) * 2002-01-29 2003-07-31 Felix Rosenkranz Barricade-penetrator
US20030159612A1 (en) * 2002-02-28 2003-08-28 Terrance Ziemack Ballistic implant system and methods
US6584910B1 (en) 2002-04-19 2003-07-01 David J. Plass Animal syringe system

Similar Documents

Publication Publication Date Title
US979993A (en) Projectile.
Reitz Commando: A Boer Journal of the Boer War [Illustrated Edition]
FI69367C (en) KULA FOER FINKALIBRIGT VAPEN
US1536164A (en) Projectile
US3502025A (en) Nonpenetrating drug injecting bullet
Kistler Animals in the Military: From Hannibal's Elephants to the Dolphins of the US Navy
US693329A (en) Projectile.
Norton The Attack and Defense of Little Round Top, Gettysburg, July 2, 1863
Kritzinger In the shadow of death
Morton Sparks from the Camp Fire: Or, Tales of the Old Veterans. Thrilling Stories of Heroic Deeds... as Re-told To-day Around the Modern Camp Fire
Lyman Japan's Last Bid for Victory: The Invasion of India, 1944
Cooke The Life of Stonewall Jackson: From Official Papers, Contemporary Narratives, and Personal Acquaintance
Croll Landmines in War and Peace: From Their Origin to Present Day
Hiley et al. The Mobile Boer: Being the Record of the Observations of Two Brugher Officers
Kurowski Panzer Aces II: Battle Stories of German Tank Commanders in World War II
RU189190U1 (en) CARRIER FOR SMALL ARMS
Nolan Death Valley: The Summer Offensive, I Corps, August 1969
Dunkerly The Battle of Kings Mountain: Eyewitness Accounts
RU179154U1 (en) High-explosive fragmentation projectile
Wittenberg Protecting the Flank at Gettysburg: The Battles for Brinkerhoff’s Ridge and East Cavalry Field, July 2-3, 1863
Snook Like Wolves on the Fold: The Defence of Rorke's Drift
Hutton Sgt. Reckless: AmericaÕs War Horse
RU2610021C1 (en) Bullet for pneumatic non-lethal weapon
US97693A (en) Improvement in gun-harpoons
Perrett Against All Odds!